The effect of risedronate on posterior lateral spinal fusion in a rat model.
OBJECTIVE
To evaluate the potential effects of risedronate (RIS) which shows a higher anti-resorptive effect among bisphosphonates, after a posterolateral lumbar intertransverse process spinal fusion using both autograft and allograft in a rat model.


METHODS
A totoal of 28 Sprague-Dawley rats were randomized into 2 study groups. A posterolateral lumbar intertransverse process spinal fusion was peformed using both autograft and allograft in a rat model. Group I (control) received 0.1 mL of steril saline (placebo) and Group II (treatment) received risedronate, equivalent to human dose (10 microg/kg/week) for 10-weeks period.


RESULTS
The fusion rates as determined by manual palpation were 69% in the group I and 46% in the group II (p = 0.251). According to radiographic score, the spinal segment was considered to be fused radiographically in 7 (53%) of the 13 controls and 9 (69%) of the 13 rats treated with RIS (p = 0.851). The mean histological scores were 5.69 +/- 0.13 and 3.84 +/- 0.43 for the control and treatment groups, respectively. There was a significant difference between the both groups (p = 0.001). The mean bone density of the fusion masses was 86.9 +/- 2.34 in the control group and 106.0 +/- 3.54 in the RIS treatment group. There was a statistical difference in mean bone densities of the fusion masses comparing the two groups (p = 0.001).


CONCLUSIONS
In this study, risedronate appears to delay bone fusion in a rat model. This occurs as a result of uncoupling the balanced osteoclastic and osteoblastic activity inherent to bone healing. These findings suggest that a discontinuation of risedronate postoperatively during acute fusion period may be warranted.
Gezici
Ali Riza
AR
Department of Neurosurgery, Faculty of Medicine, Abant Izzet Baysal University, Bolu, Turkey.
Ergün
Rüçhan
R
Gürel
Kamil
K
Yilmaz
Fahri
F
Okay
Onder
O
Bozdoğan
Omer
O
Spine (Phila Pa 1976). 2005 Nov 15;30(22):2516-22
16284589
J Bone Joint Surg Am. 2002 Oct;84(10):1763-8
12377905
Orthop Clin North Am. 1998 Oct;29(4):603-19
9756958
J Urol. 2004 Dec;172(6 Pt 1):2137-44
15538219
J Craniofac Surg. 1998 Sep;9(5):448-51
9780914
Spine J. 2004 Jan-Feb;4(1):36-43
14749192
Semin Oncol. 2001 Apr;28(2 Suppl 6):35-44
11346863
Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S26-31
12205416
Spine (Phila Pa 1976). 1995 Feb 15;20(4):412-20
7747224
J Bone Joint Surg Am. 1994 Apr;76(4):540-8
8150821
J Bone Miner Res. 2002 Aug;17(8):1498-511
12162504
J Nutr Sci Vitaminol (Tokyo). 2006 Oct;52(5):307-15
17190100
Spine (Phila Pa 1976). 1993 Jun 15;18(8):983-91
8367786
Br J Haematol. 1998 Feb;100(2):317-25
9488619
Spine (Phila Pa 1976). 1996 Jan 1;21(1):27-31
9122759
Spine (Phila Pa 1976). 2004 Jun 15;29(12):1308-13
15187630
Aust N Z J Surg. 1999 Oct;69(10):726-8
10527350
Osteoporos Int. 1993;3 Suppl 3:S13-6
8298197
Braz Oral Res. 2006 Jul-Sep;20(3):196-201
17119700
Acta Orthop Scand. 2003 Oct;74(5):596-603
14620983
Curr Opin Nephrol Hypertens. 2002 Nov;11(6):641-7
12394611
JAMA. 1999 Oct 13;282(14):1344-52
10527181
Clin Orthop Relat Res. 2004 Aug;(425):135-42
15292798
J South Orthop Assoc. 2000 Summer;9(2):91-7
10901646
Bone. 1999 May;24(5 Suppl):73S-79S
10321934
J Periodontal Res. 2001 Aug;36(4):244-51
11519698
Spine (Phila Pa 1976). 1999 Jul 15;24(14):1402-5
10423783
N Engl J Med. 2003 Feb 13;348(7):618-29
12584371
Pharm Res. 2001 Feb;18(2):166-70
11405286
N Engl J Med. 1996 Feb 22;334(8):488-93
8559201
Spine (Phila Pa 1976). 2001 Jul 1;26(13):1473-6
11458153
Blood. 2001 Sep 1;98(5):1616-8
11520816
Spine (Phila Pa 1976). 2007 Jan 1;32(1):36-41
17202890
J Periodontol. 2000 May;71(5):790-6
10872961
Cancer Res. 2000 Nov 1;60(21):6001-7
11085520
J Bone Joint Surg Am. 1997 May;79(5):756-9
9160949
Spine J. 2006 Jul-Aug;6(4):391-6
16825044
J Bone Miner Metab. 2004;22(5):404-14
15316861
Spine (Phila Pa 1976). 2005 May 15;30(10):1116-21
15897823
J Nutr Sci Vitaminol (Tokyo). 2006 Dec;52(6):393-401
17330501
J Intern Med. 2004 Jan;255(1):1-12
14687233
Clin Orthop Relat Res. 1992 Nov;(284):80-90
1395317
Osteoporos Int. 2000;11(1):83-91
10663363
Lancet. 2002 Jun 8;359(9322):2018-26
12076571